roger montgomery - the australian, page-5

'I believe most of us understand the significant upside opportunity presented by SRX's large randomised controlled trials, but I haven't seen any discussion of their trial of sir-spheres in kidney cancer. See http://www.anzctr.org.au/TrialSearch.aspx'

Last time I saw any data the recruitment was so far behind schedule it was disappointing to say the least. Europe is Theraspheres playground and I think SRX are having a very hard time there - IMO